Mastek Ltd

Q3 FY23 Earnings Call Analysis

IT - Software

Full Stock Analysis
margin: Category 2orderbook: Yesfundraise: No informationcapex: Yesrevenue: Category 3
💰

fundraise

Any current/future new fundraising through debt or equity?

- There is no mention of any new fundraising through debt or equity in the discussed pages. - The company has borrowed USD 16.7 million during the quarter specifically for the BizAnalytica acquisition. - The remaining acquisition amount was paid from internal cash accruals. - Current borrowings stand at INR 477 crores as of September 30, 2023. - The company has been focusing on paying down existing loans as per schedule, including dividend payments and loan installments. - No indication of plans for future debt or equity fundraising provided in the disclosed information.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- The document does not explicitly detail any specific current or future capex or strategic capital investments. - However, Mastek is making significant investments in developing capabilities around Generative AI, including: - Training people. - Building specific solutions related to Generative AI. - They are also investing in inorganic growth via acquisitions, such as BizAnalytica, which complements their data cloud business and overall value proposition. - Investments are being made in platform partnerships with Salesforce, Snowflake, Oracle, and Microsoft to amplify go-to-market positioning. - There is a focus on cost optimization initiatives to improve margins. - Given the emphasis on digital engineering, cloud transformation, and innovation, such as their Enterprise Workforce Scheduler platform, ongoing investments in technology and talent can be inferred.
📊

revenue

Future growth expectations in sales/revenue/volumes?

- Mastek aims for steady, double-digit year-on-year revenue growth in upcoming quarters, targeting a few percentage points above industry averages. - U.S. business is on a strong growth trajectory with 5% quarter-on-quarter organic growth, surpassing USD 100 million run rate, and expected to continue momentum. - Healthcare vertical in the U.S. is seen as a significant growth opportunity, potentially becoming a USD 100 million vertical in 3-4 years. - U.K. public sector remains resilient with strong order booking and expected continued growth, particularly in central government and public sector. - Inorganic growth through acquisitions like BizAnalytica to contribute positively with margin improvements over time. - Growth drivers include expanded service portfolio, order backlog strength, and mining larger account deals. - Geographies like Middle East and selective European markets also expected to grow steadily. - Management cautiously optimistic given macro uncertainties but confident due to strong order book and enhanced capabilities.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- Mastek aims for steady double-digit year-on-year revenue growth, targeting a few percentage points above industry growth. - U.S. business, after achieving over USD 100 million run rate, is expected to sustain 5% quarter-on-quarter growth; margins targeted to reach double digits and gradually approach company average within 2-3 quarters. - Operating EBITDA margins impacted by recent wage hikes and BizAnalytica integration; management plans to use operating levers like grade mix, subcontractor conversion to employees, and utilization improvement to restore margins. - EBITDA margin target range is 17% to 19%, with efforts to reach the upper end once operational efficiencies and U.S. growth stabilize. - One-time acquisition costs impacting current profitability will not recur, supporting PAT improvement next quarters. - Order backlog growth and strong deal pipeline in UK and US provide confidence for improved future profitability and earnings growth.
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

- 12-month order backlog grew approximately 13.4% year-on-year on a constant currency basis. - In INR and USD terms, the order book growth is even higher. - Order booking in the U.K. improved significantly, reflecting strong order book momentum. - The U.K. order backlog grew 5.6% quarter-on-quarter and 22.3% year-on-year in INR terms. - Steady growth is seen in both U.K. and U.S., with the U.K. order book better in Q2 and U.S. order book stronger in Q1. - The order book proportion balances out over half-year periods relative to revenue. - Average deal close time varies significantly from 1 month to 7 months based on deal complexity. - The strong order book gives confidence for revenue growth in upcoming quarters.